Acelyrin Inc. Delists from Nasdaq Following Merger, Becomes Wholly Owned Subsidiary of Alumis
I'm PortAI, I can summarize articles.
Acelyrin Inc. has completed a merger with Alumis, becoming a wholly owned subsidiary. Following this change of control, Acelyrin has notified Nasdaq to suspend trading of its common stock and plans to delist from Nasdaq and deregister under the Securities Exchange Act of 1934. The company will also terminate its reporting obligations and its 2023 Employee Stock Purchase Plan.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments